Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox pseudogene" (ENSG00000282432) is a pseudogene, meaning it is a DNA sequence similar to a functional gene but typically contains mutations that prevent the production of a functional protein. Pseudogenes may arise through duplication or retrotransposition events and generally do not encode active proteins. Some pseudogenes can be transcribed and have limited regulatory roles at the RNA level, such as acting as competitive endogenous RNAs or microRNA decoys, but there is no evidence that this specific double homeobox pseudogene (ENSG00000282432) has any known biological function, clinical relevance, or role as a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox pseudogene (None).